Soon after rapamycin, the first mTOR inhibitor, emerged in 1990s as a potential treatment against unwanted cell proliferation, many cancer experts had hoped emerging drugs targeting mTOR would become...

Russia on Monday reported a new record increase in coronavirus infections, as some experts said the pandemic had hit the country harder that government statistics suggest. Health officials reported 493...

Coronavirus vaccines were supposed to be “the light at the end of the tunnel” for the ongoing global pandemic—a sign that, finally, the virus was going to be beaten back. That was the...

The time period between Thanksgiving and Christmas is characterized by overindulgence. While we tell others that we are eating and drinking in moderation, controlling our spending, and exercising more,...

The coronavirus pandemic has now killed more than 10,000 residents in Belgian retirement homes, more than half of the national death toll, health officials said Friday. Belgium, a country of 11.5 million...

(HealthDay)—Among people with skin of color, ultraviolet (UV) exposure may not be an important risk factor for melanoma, according to a review published online Dec. 16 in JAMA Dermatology. Fabiana C.P.S....

Chemotherapy attacks all cells in our body and not just cancer cells, which is why patients undergoing the treatment often experience side effects such as physical weakness, hair loss and nausea. However,...

A team of scientists has shown that a key type of immune cell “self-renews” in humans. It is an unexpected discovery, as it was previously thought this specific type of “senescent”...

A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows. The results may lead to new approaches...

The first shots of COVID-19 vaccine are being delivered, but it will likely be months before doses are widely available for everyone at U.S. drugstores and doctor’s office. Details are still being...